Leo Wealth LLC’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-4,275
Closed -$347K 401
2025
Q1
$347K Hold
4,275
0.05% 204
2024
Q4
$385K Sell
4,275
-6
-0.1% -$581 0.03% 256
2024
Q3
$423K Buy
4,281
+1,002
+31% +$98.4K 0.04% 243
2024
Q2
$304K Buy
3,279
+702
+27% +$62.9K 0.03% 269
2024
Q1
$245K Buy
2,577
+260
+11% +$24.1K 0.03% 294
2023
Q4
$207K Buy
+2,317
New +$172K 0.02% 309

Other funds holding XBI

Leo Wealth LLC's XBI Position: Q2 2025 in Review

Leo Wealth LLC sold out of State Street SPDR S&P Biotech ETF (XBI) in Q2 2025, closing a stake of 4,275 shares — an estimated $347K sold.

Leo Wealth LLC first reported a position in XBI in Q4 2023 and held it in 6 quarters. The position peaked at $423K in Q3 2024. 625 funds tracked by Wall St. Rank hold XBI as of Q2 2025.

  • Leo Wealth LLC reported no remaining State Street SPDR S&P Biotech ETF position as of Q2 2025 after selling out during the quarter.
  • Leo Wealth LLC sold 4,275 State Street SPDR S&P Biotech ETF shares in Q2 2025, an estimated $347K.
  • Leo Wealth LLC first reported a position in State Street SPDR S&P Biotech ETF in Q4 2023 and held it in 6 quarters.
  • Leo Wealth LLC's State Street SPDR S&P Biotech ETF position peaked at $423K in Q3 2024.
  • 625 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2025.

Based on Leo Wealth LLC's 13F filing for Q2 2025, filed 24 Jul 2025.